MICROBIAL PRODUCTION - Cutting-edge inABLE® technology: The key to cost-effective production of a novel antimicrobial peptide with potential for the treatment of MRSA (2016)
Abstract
No abstract provided
Bibliographic Information
Publication URI: https://api.elsevier.com/content/abstract/scopus_id/84975815536
Type: Other
Volume: 16
Parent Publication: Drug Development and Delivery
Issue: 5
ISSN: 1944818X 15372898